Resumen
The blood-brain barrier (BBB) is a formidable physical and enzymatic barrier that tightly controls the passage of molecules from the blood to the brain. In fact, less than 2 % of all potential neurotherapeutics are able to cross it. Here, by applying the retro-enantio approach to a peptide that targets the transferrin receptor, a full protease-resistant peptide with the capacity to act as a BBB shuttle was obtained and thus enabled the transport of a variety of cargos into the central nervous system.
Idioma original | Inglés |
---|---|
Páginas (desde-hasta) | 3967-3972 |
Número de páginas | 6 |
Publicación | Angewandte Chemie - International Edition |
Volumen | 54 |
N.º | 13 |
DOI | |
Estado | Publicada - 23 mar 2015 |
Publicado de forma externa | Sí |